133 related articles for article (PubMed ID: 22045627)
1. Involvement of the cGMP pathway in the osthole-facilitated glutamate release in rat hippocampal nerve endings.
Lin TY; Lu CW; Huang WJ; Wang SJ
Synapse; 2012 Mar; 66(3):232-9. PubMed ID: 22045627
[TBL] [Abstract][Full Text] [Related]
2. Osthole and imperatorin, the active constituents of Cnidium monnieri (L.) Cusson, facilitate glutamate release from rat hippocampal nerve terminals.
Wang SJ; Lin TY; Lu CW; Huang WJ
Neurochem Int; 2008 Dec; 53(6-8):416-23. PubMed ID: 18951936
[TBL] [Abstract][Full Text] [Related]
3. Osthole or imperatorin-mediated facilitation of glutamate release is associated with a synaptic vesicle mobilization in rat hippocampal glutamatergic nerve endings.
Lin TY; Lu CW; Huang WJ; Wang SJ
Synapse; 2010 May; 64(5):390-6. PubMed ID: 20034017
[TBL] [Abstract][Full Text] [Related]
4. Facilitatory effect of aspirin on glutamate release from rat hippocampal nerve terminals: involvement of protein kinase C pathway.
Wang SJ
Neurochem Int; 2006 Feb; 48(3):181-90. PubMed ID: 16330128
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
[TBL] [Abstract][Full Text] [Related]
6. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide-evoked glutamate release and cGMP production in cerebellar slices: control by presynaptic 5-HT1D receptors.
Marcoli M; Cervetto C; Paluzzi P; Guarnieri S; Raiteri M; Maura G
Neurochem Int; 2006 Jul; 49(1):12-9. PubMed ID: 16469416
[TBL] [Abstract][Full Text] [Related]
8. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca(2+) entry and mitogen-activated protein kinase signaling pathway.
Lin TY; Lu CW; Wang SJ
J Agric Food Chem; 2010 Jul; 58(14):8271-8. PubMed ID: 20593829
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic mechanisms underlying the alpha-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals.
Wang SJ; Chen HH
Neurochem Int; 2007 Jan; 50(1):51-60. PubMed ID: 16949179
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus.
Rodríguez-Moreno A; Sihra TS
J Physiol; 2004 Jun; 557(Pt 3):733-45. PubMed ID: 15107475
[TBL] [Abstract][Full Text] [Related]
11. Both protein kinase G dependent and independent mechanisms are involved in the modulation of glutamate release by nitric oxide in rat hippocampal nerve terminals.
Sequeira SM; Carvalho AP; Carvalho CM
Neurosci Lett; 1999 Feb; 261(1-2):29-32. PubMed ID: 10081919
[TBL] [Abstract][Full Text] [Related]
12. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals.
Lin TY; Yang TT; Lu CW; Wang SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):598-606. PubMed ID: 21216268
[TBL] [Abstract][Full Text] [Related]
14. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
15. Caffeine facilitation of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) through activation protein kinase C pathway: an interaction with presynaptic adenosine A1 receptors.
Wang SJ
Synapse; 2007 Jun; 61(6):401-11. PubMed ID: 17372967
[TBL] [Abstract][Full Text] [Related]
16. cGMP/protein kinase G-dependent potentiation of glutamatergic transmission induced by nitric oxide in immature rat rostral ventrolateral medulla neurons in vitro.
Huang CC; Chan SH; Hsu KS
Mol Pharmacol; 2003 Aug; 64(2):521-32. PubMed ID: 12869658
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan.
Lin TY; Lu CW; Wang SJ
Neurochem Int; 2009 Jul; 54(8):526-34. PubMed ID: 19428798
[TBL] [Abstract][Full Text] [Related]
18. The phosphodiesterase III inhibitor olprinone inhibits hippocampal glutamate release via a cGMP/PKG pathway.
Fujikawa H; Kanno T; Nagata T; Nishizaki T
Neurosci Lett; 2008 Dec; 448(2):208-11. PubMed ID: 18983890
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.
Neitz A; Mergia E; Eysel UT; Koesling D; Mittmann T
Eur J Neurosci; 2011 May; 33(9):1611-21. PubMed ID: 21410795
[TBL] [Abstract][Full Text] [Related]
20. Modulation of presynaptic glucocorticoid receptors on glutamate release from rat hippocampal nerve terminals.
Wang CC; Wang SJ
Synapse; 2009 Sep; 63(9):745-51. PubMed ID: 19484722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]